Suvi M. Virtanen

Suvi M. Virtanen


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in The Lancet
Verified
Journal Article
Closed access
EHElina Hyppönen
Elina Hyppönen
ELEsa Läärä
Esa Läärä
ARAntti Reunanen
Antti Reunanen
MJMarjo-Riitta Järvelin
Marjo-Riitta Järvelin
SVSuvi M. Virtanen
Suvi M. Virtanen

1 February 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
AKAleksandar D. Kostic
Aleksandar D. Kostic
DGDirk Gevers
Dirk Gevers
HSHeli Siljander
Heli Siljander
Tommi VatanenTommi Vatanen
Tommi Vatanen
Tuulia HyötyläinenTuulia Hyötyläinen
Tuulia Hyötyläinen
RXRamnik J. Xavier
Ramnik J. Xavier

1 May 2016 in Cell
Verified
Journal Article
Closed access
Tommi VatanenTommi Vatanen
Tommi Vatanen
AKAleksandar D. Kostic
Aleksandar D. Kostic
EDEva D’hEnnezel
Eva D’hEnnezel
HSHeli Siljander
Heli Siljander
EFEric A. Franzosa
Eric A. Franzosa
RXRamnik J. Xavier
Ramnik J. Xavier

1 July 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
MYMoran Yassour
Moran Yassour
EJEeva Jason
Eeva Jason
LHLarson J. Hogstrom
Larson J. Hogstrom
TATimothy D. Arthur
Timothy D. Arthur
STSurya Tripathi
Surya Tripathi
RXRamnik J. Xavier
Ramnik J. Xavier

1 December 2005 in Diabetes
Verified
Journal Article
Closed access
PDF file
MKMikael Knip
Mikael Knip
RVRiitta Veijola
Riitta Veijola
SVSuvi M. Virtanen
Suvi M. Virtanen
HHHeikki Hyöty
Heikki Hyöty
OVOuti Vaarala
Outi Vaarala
HAHans K. ÅkErblom
Hans K. ÅkErblom
Type 1 diabetes is perceived as a chronic immune-mediated disease with a subclinical prodromal period characterized by selective loss of insulin-producing β-cells in the pancreatic islets in genetically susceptible subjects. A series of evidence supports a critical role of exogenous factors in the development of type 1 diabetes, such as 1) the fact that <10% of individuals with HLA-conferred diabetes susceptibility do progress to clinical disease, 2) a pairwise concordance of type 1 diabetes of <40% among monozygotic twins, 3) a more than 10-fold difference in the disease incidence among Caucasians living in Europe, 4) a several-fold increase in the incidence over the last 50 years, and 5) migration studies indicating that the disease incidence has increased in population groups who have moved from a low-incidence to a high-incidence region. This article discusses the trigger-booster hypothesis claiming that the diabetic disease process is triggered by an exogenous factor with definite seasonal variation and driven by one or several other environmental determinants. In addition, there are a series of modifying factors affecting the fate and pace of the process. Accordingly, progression to clinical type 1 diabetes typically requires the unfortunate combination of genetic disease susceptibility, a diabetogenic trigger, and a high exposure to a driving antigen.

1 August 1995 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
EFEdith Feskens
Edith Feskens
SVSuvi M. Virtanen
Suvi M. Virtanen
LRLeena Räsänen
Leena Räsänen
JTJaakko Tuomilehto
Jaakko Tuomilehto
JSJari Stengård
Jari Stengård
DKDaan Kromhout
Daan Kromhout
OBJECTIVE: To investigate the role of diet as a predictor of glucose intolerance and non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS: At the 30-year follow-up survey of the Dutch and Finnish cohorts of the Seven Countries Study, in 1989/1990, men were examined according to a standardized protocol including a 2-h oral glucose tolerance test. Information on habitual food consumption was obtained using the cross-check dietary history method. Those 338 men in whom information on habitual diet was also available 20 years earlier were included in this study. Subjects known as having diabetes in 1989/1990 were excluded from the analyses. RESULTS: Adjusting for age and cohort, the intake of total, saturated, and monounsaturated fatty acids and dietary cholesterol 20 years before diagnosis was higher in men with newly diagnosed diabetes in the survey than in men with normal or impaired glucose tolerance. After adjustment for cohort, age, past body mass index, and past energy intake, the past intake of total fat was positively associated with 2-h postload glucose level (P < 0.05). An independent inverse association with the past intake of vitamin C was observed (P < 0.05). These associations were independent of changes in the intake of fat and vitamin C during the 20-year follow-up. An increase in the consumption of vegetables and legumes, potatoes, and fish during the 20-year follow-up was inversely related with 2-h glucose level (P < 0.05). CONCLUSIONS: Although the regression coefficients were in general not very large, these results indicate that a high intake of fat, especially that of saturated fatty acids, contributes to the risk of glucose intolerance and NIDDM. Foods such as fish, potatoes, vegetables, and legumes may have a protective effect. In addition, the observed inverse association between vitamin C and glucose intolerance suggests that antioxidants may also play a role in the development of derangements in glucose metabolism.